Amends TCA Title 53 and Title 63.

Tennessee SB0282, now signed into law, establishes the "Individualized Investigational Treatment Act," which allows eligible patients with life-threatening or severely debilitating illnesses to request individualized investigational treatments from manufacturers or eligible facilities based on their genetic profiles. Key provisions include requirements for informed consent, the option for patients to pay for treatments, and protections for healthcare providers against disciplinary actions related to recommendations for such treatments. The law does not mandate coverage for these treatments by insurance providers or state agencies.